About Longitude Capital
Longitude Capital is a private equity firm founded in 2006. It is primarily based in Menlo Park, United States. As of Oct 2026, Longitude Capital is an active investor with a portfolio of 114 companies, comprising 114 funding rounds and 1 acquisition. In the last 12 months, it has participated in 4 funding rounds. The firm primarily invests in companies based in United States and Ireland. Its portfolio is spread across a wide range of sectors from Life Sciences to HealthTech. Its latest investment was a $***** Series A round in Campfield Care on May 20, 2026 which also saw participation from Frazier Life Sciences, Deep Track Capital and other investors.
Overall Longitude Capital portfolio has seen 2 unicorns, 28 IPOs and 32 acquisitions including key companies like Jazz Pharmaceuticals, PROCEPT BioRobotics and Ceribell. A lot of funds co-invest with Longitude Capital, with names like Orbimed sharing a substantial percentage of its portfolio.
Longitude Capital has a team of 18 people, including 4 partners.
Key Metrics
Founded Year
2006
Location
Menlo Park, United States
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Acquisition Deals
Investment Deals
Longitude Capital's Portfolio
Longitude Capital has a portfolio of 114 companies. They have invested in a total of 114 companies. Their most recent investment was in Campfield Care (Series A round) on May 20, 2026. Here is the most recent investment by Longitude Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
May 20, 2026 | Series A | 5356 | ||
Jan 09, 2026 | Series A | 2310 | ||
Jan 06, 2026 | Series A | 8344 | ||
Oct 14, 2025 | Series C | 4719 |
Longitude Capital has acquired 1 company. Their most recent acquisition was of California Cryobank on Jun 15, 2018. Here is the most recent acquisition by Longitude Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Jun 15, 2018 | Reproductive tissue bank providing sperm, egg donor services, and cord blood banking | - | 1977 |
Here is the portfolio snapshot of Longitude Capital:
Investments by Year
The maximum number of investments were made in 2021
Portfolio by Location
Companies are primarily in United States and Ireland
Portfolio by Sector
Companies are primarily in Life Sciences
Team profile of Longitude Capital
Longitude Capital has a team of 18 members including 4 Partners and 5 Principals located in United States. Longitude Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Longitude Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Menlo Park | - | ||
Partner | Menlo Park | - | ||
Partner | Berkeley | - | ||
Partner | Menlo Park | - | - | |
Principal | San Francisco | - | ||
Principal | Cambridge | - | ||
Principal | Menlo Park | - | ||
Principal | San Francisco | - | - | |
Principal | Atlanta | - | - | |
Advisor | Mill Valley | - | - | |
Associate | San Francisco | - | - |
Co-investors of Longitude Capital
Over the past 20 years, 177 investors have co-invested in Longitude Capital's portfolio companies.
- Top Co-investors of Longitude Capital: 177 investors entered a company along with Longitude Capital. These include investors like Orbimed (9 companies).
Longitude Capital News
•
cAMPfield harvests $180M series A to advance oral IBD drug licensed from NewsoaraFierce Biotech•Jun 18, 2026•Campfield Care, Novo Holdings, Venrock, Abingworth and 2 others
•
MicroTransponder Secures $65 Million to Expand Access to Vivistim® Therapy for Chronic Stroke RecoveryG-MedTech•Mar 13, 2026•Osage University Partners, Gilde Healthcare, Longitude Capital, Action Potential Venture Capital and 4 others
•
AirNexis Therapeutics Raises $200M in Series A FundingFinSMEs•Jan 12, 2026•Frazier Life Sciences, Enavate Sciences, Orbimed, Goldman Sachs and 7 others
•
Ventaris Surgical Raises $30M in Series A FundingFinSMEs•Jan 12, 2026•Atypical, Vensana Capital, Longitude Capital, Neotribe and 3 others
•
WisdomAI Secures $50M Series A Funding Round Led by Kleiner PerkinsMassinvestor•Nov 13, 2025•NVentures, Coatue, Kleiner Perkins, Longitude Capital and 14 others
•
Veradermics Announces Oversubscribed $150 Million Series C Financing to Advance VDPHL01 Through Multiple Phase 3 Trials as Potentially the First Non-Hormonal Oral Therapeutic for Hair Regrowth in Women and Menintelligence360•Nov 12, 2025•Suvretta Capital Management, VeraDermics, Invus, Marshall Wace and 18 others
•
Cohere Health Secures $90M Series C to Expand AI-Powered Platform Transforming Health Plan Clinical Decision-Makingintelligence360•May 23, 2025•Cohere Health, Temasek, Deerfield, Define Ventures and 3 others
•
Cohere Health Raises $90M in Series C FundingFinSMEs•May 14, 2025•Cohere Health, Temasek, Deerfield, Define Ventures and 3 others
•
CytomX Therapeutics Announces $100 Million Common Stock OfferingBenzinga•May 12, 2025•CytomX Therapeutics, Longitude Capital, Orbimed, Venrock and 4 others
•
MicroTransponder receives $65m to advance stroke care with VivistimMedicalDeviceNetwork•Mar 13, 2025•MicroTransponder, Usventure, Exceller Hunt, Green Park & Golf Ventures and 6 others
